Literature DB >> 8033087

Frequent p53 gene mutations and novel alleles in familial breast cancer.

O K Glebov1, K E McKenzie, C A White, S Sukumar.   

Abstract

Mutations in the p53 gene were detected in 58% of tumor DNAs of patients with a family history of breast cancer (FHBC) compared to 13% with sporadic breast cancer. Seven of 18 FHBC tumors contained the same G to C transversion in codon 156. Novel alleles of altered length were seen in one or more loci on chromosome 17 in 15 of 18 patients with FHBC but only in a single locus in 8 of 14 patients with sporadic breast cancer. The frequency of tumors with mutations in p53, often multiple, accompanied by the appearance of multiple altered-length alleles suggest that DNA replication or repair defects may presage genomic instability in cases with FHBC.

Entities:  

Mesh:

Year:  1994        PMID: 8033087

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

1.  Microsatellite instability and loss of heterozygosity in gastric carcinoma in comparison to family history.

Authors:  G Keller; M Rudelius; H Vogelsang; V Grimm; M G Wilhelm; J Mueller; J R Siewert; H Höfler
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

2.  p53 mutations and expression in breast carcinoma in situ.

Authors:  J Lukas; N Niu; M F Press
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

3.  Alterations of p16-pRb pathway and chromosome locus 9p21-22 in sporadic invasive breast carcinomas.

Authors:  V G Gorgoulis; E N Koutroumbi; A Kotsinas; P Zacharatos; C Markopoulos; L Giannikos; V Kyriakou; Z Voulgaris; I Gogas; C Kittas
Journal:  Mol Med       Date:  1998-12       Impact factor: 6.354

4.  Linkage analysis and allelic imbalance in human breast cancer kindreds using microsatellite markers from the short arm of chromosome 3.

Authors:  J T Bergthorsson; G Eiriksdottir; R B Barkardottir; V Egilsson; A Arason; S Ingvarsson
Journal:  Hum Genet       Date:  1995-10       Impact factor: 4.132

5.  Replication error phenotype and p53 gene mutation in lymphomas of mucosa-associated lymphoid tissue.

Authors:  H Peng; G Chen; M Du; N Singh; P G Isaacson; L Pan
Journal:  Am J Pathol       Date:  1996-02       Impact factor: 4.307

6.  Evolution of p53 in hypoxia-stressed Spalax mimics human tumor mutation.

Authors:  Osnat Ashur-Fabian; Aaron Avivi; Luba Trakhtenbrot; Konstantin Adamsky; Meytal Cohen; Gadi Kajakaro; Alma Joel; Ninette Amariglio; Eviatar Nevo; Gideon Rechavi
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-09       Impact factor: 11.205

7.  Identification of tumour-associated and germ line p53 mutations in canine mammary cancer.

Authors:  N Veldhoen; J Watterson; M Brash; J Milner
Journal:  Br J Cancer       Date:  1999-10       Impact factor: 7.640

8.  Screening for TP53 mutations in patients and tumours from 109 Swedish breast cancer families.

Authors:  M Zelada-Hedman; A L Børresen-Dale; A Claro; J Chen; L Skoog; A Lindblom
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

9.  Immunofluorometric analysis of p53 protein and prostate-specific antigen in breast tumours and their association with other prognostic indicators.

Authors:  M A Levesque; G M Clark; H Yu; E P Diamandis
Journal:  Br J Cancer       Date:  1995-09       Impact factor: 7.640

10.  Microsatellite instability in early sporadic breast cancer.

Authors:  J A Shaw; T Walsh; S A Chappell; N Carey; K Johnson; R A Walker
Journal:  Br J Cancer       Date:  1996-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.